Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice

Neurobiology of Disease

Volumn 18, Issue 1, 2005, Pages 89-99

  Schuessel, Katrin ^a   Schäfer, Stephanie ^b   Bayer, Thomas A ^b   Czech, Christian ^c,d   Pradier, Laurent ^d   Müller Spahn, Franz ^e   Müller, Walter E ^a   Eckert, Anne ^a,e,f  

^a GOETHE UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d SANOFI   (France)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f Geb N 260 1 OG Marie Curie S ^*  (Germany)

Author keywords

Aging; Alzheimer's disease; Amyloid beta; Amyloid precursor protein APP; Gender; Lipid peroxidation; Oxidative stress; Superoxide dismutase; Transgenic; Transgenic mouse

Indexed keywords

4 HYDROXYNONENAL; AMYLOID PRECURSOR PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SEX ROLE; TRANSGENIC MOUSE;

AGING; ALDEHYDES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; SENILE PLAQUES; SEX CHARACTERISTICS; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 11844272073     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.09.003     Document Type: Article

References (63)

1. J. Aikens, and T.A. Dix Perhydroxyl radical (HOO.) initiated lipid peroxidation. The role of fatty acid hydroperoxides J. Biol. Chem. 266 1991 15091 15098
2. K. Andersen, L.J. Launer, M.E. Dewey, L. Letenneur, A. Ott, J.R. Copeland, J.F. Dartigues, P. Kragh-Sorensen, M. Baldereschi, C. Brayne, A. Lobo, J.M. Martinez-Lage, T. Stijnen, and A. Hofman Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM incidence research group Neurology 53 1999 1992 1997
3. C.S. Atwood, R.D. Moir, X. Huang, R.C. Scarpa, N.M. Bacarra, D.M. Romano, M.A. Hartshorn, R.E. Tanzi, and A.I. Bush Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis J. Biol. Chem. 273 1998 12817 12826
4. T.A. Bayer, S. Schafer, A. Simons, A. Kemmling, T. Kamer, R. Tepest, A. Eckert, K. Schussel, O. Eikenberg, C. Sturchler-Pierrat, D. Abramowski, M. Staufenbiel, and G. Multhaup Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice Proc. Natl. Acad. Sci. U. S. A. 100 2003 14187 14192
5. C. Behl, J.B. Davis, R. Lesley, and D. Schubert Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77 1994 817 827
6. V. Blanchard, C. Czech, B. Bonici, N. Clavel, M. Gohin, K. Dalet, F. Revah, L. Pradier, A. Imperato, and S. Moussaoui Immunohistochemical analysis of presenilin 2 expression in the mouse brain: distribution pattern and co-localization with presenilin 1 protein Brain Res. 758 1997 209 217
7. V. Blanchard, S. Moussaoui, C. Czech, N. Touchet, B. Bonici, M. Planche, T. Canton, I. Jedidi, M. Gohin, O. Wirths, T.A. Bayer, D. Langui, C. Duyckaerts, G. Tremp, and L. Pradier Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice Exp. Neurol. 184 2003 247 263
8. N. Bogdanovic, M. Zilmer, K. Zilmer, A. Rehema, and E. Karelson The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex Dementia Geriatr. Cognit. Disord. 12 2001 364 370
9. D. Bonnes-Taourel, M.C. Guerin, J. Torreilles, I. Ceballos-Picot, and A.C. de Paulet 4-Hydroxynonenal content lower in brains of 25 month old transgenic mice carrying the human CuZn superoxide dismutase gene than in brains of their non-transgenic littermates J. Lipid Mediators 8 1993 111 120
10. C. Brayne, C. Gill, F.A. Huppert, C. Barkley, E. Gehlhaar, D.M. Girling, D.W. O'Connor, and E.S. Paykel Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge project for later life Br. J. Psychiatry 167 1995 255 262
11. D.A. Butterfield Beta-amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease Chem. Res. Toxicol. 10 1997 495 506
12. M.J. Callahan, W.J. Lipinski, F. Bian, R.A. Durham, A. Pack, and L.C. Walker Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice Am. J. Pathol. 158 2001 1173 1177
13. G.A. Carlson, D.R. Borchelt, A. Dake, S. Turner, V. Danielson, J.D. Coffin, C. Eckman, J. Meiners, S.P. Nilsen, S.G. Younkin, and K.K. Hsiao Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice Hum. Mol. Genet. 6 1997 1951 1959
14. F. Celsi, A. Ferri, A. Casciati, N. D'Ambrosi, G. Rotilio, A. Costa, C. Volonte, and M.T. Carri Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators Neurochem. Int. 44 2004 25 33
15. M. Citron, T. Oltersdorf, C. Haass, L. McConlogue, A.Y. Hung, P. Seubert, C. Vigo-Pelfrey, I. Lieberburg, and D.J. Selkoe Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production Nature 360 1992 672 674
16. E.H. Corder, E. Ghebremedhin, M.G. Taylor, D.R. Thal, T.G. Ohm, and H. Braak The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism Ann. N. Y. Acad. Sci. 1019 2004 24 28
17. H. Esterbauer, and K.H. Cheeseman Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal Methods Enzymol. 186 1990 407 421
18. L. Fratiglioni, M. Viitanen, E. von Strauss, V. Tontodonati, A. Herlitz, and B. Winblad Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm Neurology 48 1997 132 138
19. D. Gerard-Monnier, I. Erdelmeier, K. Regnard, N. Moze-Henry, J.C. Yadan, and J. Chaudiere Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation Chem. Res. Toxicol. 11 1998 1176 1183
20. G.E. Gibson, and H.M. Huang Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease Front. Biosci. 7 2002 d1007 d1015
21. G.K. Gouras, J. Tsai, J. Naslund, B. Vincent, M. Edgar, F. Checler, J.P. Greenfield, V. Haroutunian, J.D. Buxbaum, H. Xu, P. Greengard, and N.R. Relkin Intraneuronal Abeta42 accumulation in human brain Am. J. Pathol. 156 2000 15 20
22. J.M. Gutteridge Lipid peroxidation initiated by superoxide-dependent hydroxyl radicals using complexed iron and hydrogen peroxide FEBS Lett. 172 1984 245 249
23. J.M. Gutteridge, A.P. Beard, and G.J. Quinlan Superoxide-dependent lipid peroxidation. Problems with the use of catalase as a specific probe for fenton-derived hydroxyl radicals Biochem. Biophys. Res. Commun. 117 1983 901 907
24. C. Haass, M.G. Schlossmacher, A.Y. Hung, C. Vigo-Pelfrey, A. Mellon, B.L. Ostaszewski, I. Lieberburg, E.H. Koo, D. Schenk, and D.B. Teplow Amyloid beta-peptide is produced by cultured cells during normal metabolism Nature 359 1992 322 325
25. O. Hagnell, L. Ojesjo, and B. Rorsman Incidence of dementia in the Lundby study Neuroepidemiology 11 Suppl. 1 1992 61 66
26. B. Halliwell, and J.M. Gutteridge Free Radicals in Biology and Medicine 1999 Oxford Univ. Press Inc. New York
27. K. Hensley, J.M. Carney, M.P. Mattson, M. Aksenova, M. Harris, J.F. Wu, R.A. Floyd, and D.A. Butterfield A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 91 1994 3270 3274
28. L. Hesse, D. Beher, C.L. Masters, and G. Multhaup The beta A4 amyloid precursor protein binding to copper FEBS Lett. 349 1994 109 116
29. B.J. Hock Jr., and B.T. Lamb Transgenic mouse models of Alzheimer's disease Trends Genet. 17 2001 S7 12
30. C. Iadecola, F. Zhang, K. Niwa, C. Eckman, S.K. Turner, E. Fischer, S. Younkin, D.R. Borchelt, K.K. Hsiao, and G.A. Carlson SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein Nat. Neurosci. 2 1999 157 161
31. J.K. Johnson, R. McCleary, M.H. Oshita, and C.W. Cotman Initiation and propagation stages of beta-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles Brain Res. 798 1998 18 24
32. A.F. Jorm, A.E. Korten, and A.S. Henderson The prevalence of dementia: a quantitative integration of the literature Acta Psychiatr. Scand. 76 1987 465 479
33. W.T. Kimberly, M.J. LaVoie, B.L. Ostaszewski, W. Ye, M.S. Wolfe, and D.J. Selkoe Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2 Proc. Natl. Acad. Sci. U. S. A. 100 2003 6382 6387
34. M. Kraszpulski, H. Soininen, S. Helisalmi, and I. Alafuzoff The load and distribution of beta-amyloid in brain tissue of patients with Alzheimer's disease Acta Neurol. Scand. 103 2001 88 92
35. Y.M. Kuo, T.A. Kokjohn, T.G. Beach, L.I. Sue, D. Brune, J.C. Lopez, W.M. Kalback, D. Abramowski, C. Sturchler-Pierrat, M. Staufenbiel, and A.E. Roher Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains J. Biol. Chem. 276 2001 12991 12998
36. F.M. LaFerla, J.C. Troncoso, D.K. Strickland, C.H. Kawas, and G. Jay Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization J. Clin. Invest. 100 1997 310 320
37. J.Y. Lee, T.B. Cole, R.D. Palmiter, S.W. Suh, and J.Y. Koh Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice Proc. Natl. Acad. Sci. U. S. A. 99 2002 7705 7710
38. L. Letenneur, D. Commenges, J.F. Dartigues, and P. Barberger-Gateau Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France Int. J. Epidemiol. 23 1994 1256 1261
39. R. Liu, I.Y. Liu, X. Bi, R.F. Thompson, S.R. Doctrow, B. Malfroy, and M. Baudry Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics Proc. Natl. Acad. Sci. U. S. A. 100 2003 8526 8531
40. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J. Biol. Chem. 193 1951 265 275
41. C.J. Maynard, R. Cappai, I. Volitakis, R.A. Cherny, A.R. White, K. Beyreuther, C.L. Masters, A.I. Bush, and Q.X. Li Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron J. Biol. Chem. 277 2002 44670 44676
42. P.B. McCray, D.D. Gibson, K.L. Fong, and K.R. Hornbrook Effect of glutathione peroxidase activity on lipid peroxidation in biological membranes Biochim. Biophys. Acta 431 1976 459 468
43. Y. Mizuno, and K. Ohta Regional distributions of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains J. Neurochem. 46 1986 1344 1352
44. P.K. Molsa, R.J. Marttila, and U.K. Rinne Epidemiology of dementia in a Finnish population Acta Neurol. Scand. 65 1982 541 552
45. G. Munch, R. Schinzel, C. Loske, A. Wong, N. Durany, J.J. Li, H. Vlassara, M.A. Smith, G. Perry, and P. Riederer Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts J. Neural Transm. 105 1998 439 461
46. C. Nebot, M. Moutet, P. Huet, J.Z. Xu, J.C. Yadan, and J. Chaudiere Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol Anal. Biochem. 214 1993 442 451
47. D.E. Paglia, and W.N. Valentine Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J. Lab. Clin. Med. 70 1967 158 169
48. A.L. Phinney, B. Drisaldi, S.D. Schmidt, S. Lugowski, V. Coronado, Y. Liang, P. Horne, J. Yang, J. Sekoulidis, J. Coomaraswamy, M.A. Chishti, D.W. Cox, P.M. Mathews, R.A. Nixon, G.A. Carlson, P. St George-Hyslop, and D. Westaway In vivo reduction of amyloid-beta by a mutant copper transporter Proc. Natl. Acad. Sci. U. S. A. 100 2003 14193 14198
49. R. Radi, J.S. Beckman, K.M. Bush, and B.A. Freeman Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide Arch. Biochem. Biophys. 288 1991 481 487
50. G. Sandberg, W. Stewart, J. Smialek, and J.C. Troncoso The prevalence of the neuropathological lesions of Alzheimer's disease is independent of race and gender Neurobiol. Aging 22 2001 169 175
51. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, and S. Younkin Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Nat. Med. 2 1996 864 870
52. C. Schmitz, B.P. Rutten, A. Pielen, S. Schafer, O. Wirths, G. Tremp, C. Czech, V. Blanchard, G. Multhaup, P. Rezaie, H. Korr, W. Steinbusch, L. Pradier, and T.A. Bayer Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease Am. J. Pathol. 164 2004 1495 1502
53. K. Schuessel, S. Leutner, N. Cairns, W.E. Muller, and A. Eckert Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain J. Neural Transm. 111 2004 1167 1182
54. D.J. Selkoe, T. Yamazaki, M. Citron, M.B. Podlisny, E.H. Koo, D.B. Teplow, and C. Haass The role of APP processing and trafficking pathways in the formation of amyloid beta-protein Ann. N. Y. Acad. Sci. 777 1996 57 64
55. M.A. Smith, P.L. Richey, S. Taneda, R.K. Kutty, L.M. Sayre, V.M. Monnier, and G. Perry Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease Ann. N. Y. Acad. Sci. 738 1994 447 454
56. R.E. Tanzi, D.M. Kovacs, T.W. Kim, R.D. Moir, S.Y. Guenette, and W. Wasco The gene defects responsible for familial Alzheimer's disease Neurobiol. Dis. 3 1996 159 168
57. M. Tien, B.A. Svingen, and S.D. Aust Superoxide dependent lipid peroxidation Fed. Proc. 40 1981 179 182
58. F. Ursini, and A. Bindoli The role of selenium peroxidases in the protection against oxidative damage of membranes Chem. Phys. Lipids 44 1987 255 276
59. F. Van Leuven Single and multiple transgenic mice as models for Alzheimer's disease Prog. Neurobiol. 61 2000 305 312
60. J. Wang, H. Tanila, J. Puolivali, I. Kadish, and T. Van Groen Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice Neurobiol. Dis. 14 2003 318 327
61. A.R. White, R. Reyes, J.F. Mercer, J. Camakaris, H. Zheng, A.I. Bush, G. Multhaup, K. Beyreuther, C.L. Masters, and R. Cappai Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice Brain Res. 842 1999 439 444
62. O. Wirths, G. Multhaup, C. Czech, V. Blanchard, S. Moussaoui, G. Tremp, L. Pradier, K. Beyreuther, and T.A. Bayer Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice Neurosci. Lett. 306 2001 116 120
63. O. Wirths, G. Multhaup, C. Czech, N. Feldmann, V. Blanchard, G. Tremp, K. Beyreuther, L. Pradier, and T.A. Bayer Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice Brain Pathol. 12 2002 275 286